

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.93507834 |
| 2 | vocalization behavior (GO:0071625) | 5.69315976 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.68150631 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37304745 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.23686395 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.20799401 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.19866793 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.02707284 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.96711844 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.89858053 |
| 11 | protein localization to synapse (GO:0035418) | 4.89787381 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.88825210 |
| 13 | regulation of cell communication by electrical coupling (GO:0010649) | 4.83548873 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.74278109 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 4.70418346 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.65229706 |
| 17 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.60933032 |
| 18 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.58479288 |
| 19 | L-amino acid import (GO:0043092) | 4.58047707 |
| 20 | glutamate secretion (GO:0014047) | 4.57578190 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.53797377 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.46850607 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.46379882 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.45131611 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.42480256 |
| 26 | neuronal action potential propagation (GO:0019227) | 4.42416528 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38435413 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.38285550 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.37090150 |
| 30 | neurotransmitter secretion (GO:0007269) | 4.36028486 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.34338693 |
| 32 | exploration behavior (GO:0035640) | 4.31589978 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 4.16725087 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.12666428 |
| 35 | muscle filament sliding (GO:0030049) | 4.07310114 |
| 36 | actin-myosin filament sliding (GO:0033275) | 4.07310114 |
| 37 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.04166400 |
| 38 | prepulse inhibition (GO:0060134) | 4.04091460 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03206588 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.02695784 |
| 41 | long-term memory (GO:0007616) | 3.97373893 |
| 42 | synaptic transmission, dopaminergic (GO:0001963) | 3.97298529 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.92060165 |
| 44 | sodium ion export (GO:0071436) | 3.91425601 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.91119394 |
| 46 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.89706140 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.88197178 |
| 48 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.84598804 |
| 49 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.82612633 |
| 50 | potassium ion homeostasis (GO:0055075) | 3.82378953 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81924382 |
| 52 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.81900805 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.81857866 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.81024970 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 3.79623713 |
| 56 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.77922964 |
| 57 | striatum development (GO:0021756) | 3.75222401 |
| 58 | regulation of relaxation of muscle (GO:1901077) | 3.74276010 |
| 59 | amino acid import (GO:0043090) | 3.72378801 |
| 60 | detection of calcium ion (GO:0005513) | 3.71728802 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.70135217 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.69171526 |
| 63 | long-term synaptic potentiation (GO:0060291) | 3.68840445 |
| 64 | positive regulation of neurotransmitter transport (GO:0051590) | 3.67373743 |
| 65 | auditory behavior (GO:0031223) | 3.66333867 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.65490764 |
| 67 | regulation of synaptic plasticity (GO:0048167) | 3.65430595 |
| 68 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.61400503 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.60990076 |
| 70 | gamma-aminobutyric acid transport (GO:0015812) | 3.60139922 |
| 71 | response to histamine (GO:0034776) | 3.59529051 |
| 72 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.59020501 |
| 73 | cerebellar granule cell differentiation (GO:0021707) | 3.58111406 |
| 74 | neuron recognition (GO:0008038) | 3.57735111 |
| 75 | behavioral fear response (GO:0001662) | 3.57632588 |
| 76 | behavioral defense response (GO:0002209) | 3.57632588 |
| 77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.54986891 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.54308722 |
| 79 | neurotransmitter transport (GO:0006836) | 3.53411459 |
| 80 | regulation of glutamate secretion (GO:0014048) | 3.50581589 |
| 81 | response to auditory stimulus (GO:0010996) | 3.46863014 |
| 82 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.45345672 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45149482 |
| 84 | regulation of female receptivity (GO:0045924) | 3.43945040 |
| 85 | neuromuscular synaptic transmission (GO:0007274) | 3.42745994 |
| 86 | cellular potassium ion homeostasis (GO:0030007) | 3.42396547 |
| 87 | response to amphetamine (GO:0001975) | 3.42366041 |
| 88 | striated muscle contraction (GO:0006941) | 3.41384520 |
| 89 | cardiac muscle contraction (GO:0060048) | 3.40368000 |
| 90 | positive regulation of vesicle fusion (GO:0031340) | 3.38737784 |
| 91 | cell communication by electrical coupling (GO:0010644) | 3.38400294 |
| 92 | neuromuscular process controlling balance (GO:0050885) | 3.37308350 |
| 93 | regulation of neurotransmitter levels (GO:0001505) | 3.35921882 |
| 94 | potassium ion import (GO:0010107) | 3.34384801 |
| 95 | fear response (GO:0042596) | 3.33871048 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.32397982 |
| 97 | activation of protein kinase A activity (GO:0034199) | 3.31641819 |
| 98 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.30626339 |
| 99 | cell communication involved in cardiac conduction (GO:0086065) | 3.30436391 |
| 100 | synaptic vesicle endocytosis (GO:0048488) | 3.29669377 |
| 101 | membrane hyperpolarization (GO:0060081) | 3.29134963 |
| 102 | learning (GO:0007612) | 3.28389850 |
| 103 | presynaptic membrane assembly (GO:0097105) | 3.28237073 |
| 104 | regulation of neurotransmitter secretion (GO:0046928) | 3.27898181 |
| 105 | membrane depolarization (GO:0051899) | 3.26972047 |
| 106 | regulation of membrane repolarization (GO:0060306) | 3.25538023 |
| 107 | regulation of actin filament-based movement (GO:1903115) | 3.23828349 |
| 108 | postsynaptic membrane organization (GO:0001941) | 3.23597765 |
| 109 | mating behavior (GO:0007617) | 3.21365115 |
| 110 | regulation of vesicle fusion (GO:0031338) | 3.21292227 |
| 111 | regulation of neurotransmitter transport (GO:0051588) | 3.21161817 |
| 112 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.21115136 |
| 113 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.21115136 |
| 114 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.21081080 |
| 115 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.21081080 |
| 116 | female mating behavior (GO:0060180) | 3.18541781 |
| 117 | skeletal muscle contraction (GO:0003009) | 3.18060449 |
| 118 | proline transport (GO:0015824) | 3.17271813 |
| 119 | presynaptic membrane organization (GO:0097090) | 3.17224163 |
| 120 | actin-mediated cell contraction (GO:0070252) | 3.17100651 |
| 121 | startle response (GO:0001964) | 3.16751558 |
| 122 | axonal fasciculation (GO:0007413) | 3.15577306 |
| 123 | dopamine receptor signaling pathway (GO:0007212) | 3.14770410 |
| 124 | positive regulation of synaptic transmission (GO:0050806) | 3.14723370 |
| 125 | neuronal ion channel clustering (GO:0045161) | 3.14519405 |
| 126 | regulation of dendritic spine development (GO:0060998) | 3.13823138 |
| 127 | synapse assembly (GO:0007416) | 3.13304593 |
| 128 | membrane depolarization during action potential (GO:0086010) | 3.12806401 |
| 129 | neuromuscular process (GO:0050905) | 3.11671879 |
| 130 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.11376945 |
| 131 | regulation of synapse maturation (GO:0090128) | 3.09977987 |
| 132 | synaptic transmission (GO:0007268) | 3.08127322 |
| 133 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08089141 |
| 134 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06475794 |
| 135 | neurotransmitter uptake (GO:0001504) | 3.06455575 |
| 136 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.05208294 |
| 137 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.05208294 |
| 138 | cardiac muscle hypertrophy (GO:0003300) | 2.98359148 |
| 139 | neuromuscular process controlling posture (GO:0050884) | 2.96680524 |
| 140 | regulation of skeletal muscle contraction (GO:0014819) | 2.86754729 |
| 141 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.84564257 |
| 142 | striated muscle hypertrophy (GO:0014897) | 2.82703954 |
| 143 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.79915308 |
| 144 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.79672651 |
| 145 | myofibril assembly (GO:0030239) | 2.79241224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.90743728 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.76897536 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.24492881 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.22399179 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17407780 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.83011761 |
| 7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75177276 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75177276 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73685792 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73117405 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72138545 |
| 12 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.57743291 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54514388 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53557057 |
| 15 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52663784 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52581077 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32315765 |
| 18 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.31199901 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29306029 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23428715 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22722721 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19597550 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11256102 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10588150 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03718858 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.02303284 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97536092 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96789449 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92834942 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92388173 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86782284 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.85213256 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83543270 |
| 34 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70527116 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69196085 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65028046 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62020676 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56443179 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53197982 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51581415 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51567608 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47219898 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41494518 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40891588 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37081736 |
| 46 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36767213 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34057345 |
| 48 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32496854 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30452331 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29742941 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28875416 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27726742 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.27643248 |
| 54 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25316310 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.23998177 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23216457 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22785707 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20808403 |
| 59 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19339645 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18850659 |
| 61 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18190485 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17998120 |
| 63 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17864258 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16032983 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15033719 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12671841 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11046560 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11046551 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09867889 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09837727 |
| 71 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08355412 |
| 72 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08318226 |
| 73 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07603659 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07234547 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06005294 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05531225 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05026956 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04888435 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04802730 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04005866 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04005866 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03245275 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02510545 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02507640 |
| 85 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02155528 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01217717 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01167067 |
| 88 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01033594 |
| 89 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00980890 |
| 90 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00964658 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98459139 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97895319 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97779757 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97581651 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94695799 |
| 96 | JUN_21703547_ChIP-Seq_K562_Human | 0.93653882 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93541919 |
| 98 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93219365 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93139757 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92843542 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92471362 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92434040 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92179322 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90372357 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89749320 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89499440 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89499440 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89411509 |
| 109 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89069917 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88911784 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88730241 |
| 112 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.88069398 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87944336 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86428189 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83493503 |
| 116 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82635157 |
| 117 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.80559358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.23882593 |
| 2 | MP0003880_abnormal_central_pattern | 5.20491920 |
| 3 | MP0002822_catalepsy | 4.68919871 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.21904536 |
| 5 | MP0009745_abnormal_behavioral_response | 3.65878644 |
| 6 | MP0004270_analgesia | 3.48105509 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.47633132 |
| 8 | MP0002064_seizures | 3.20172510 |
| 9 | MP0009046_muscle_twitch | 3.09973866 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.97460231 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.90821131 |
| 12 | MP0003646_muscle_fatigue | 2.80497828 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.69841922 |
| 14 | MP0002272_abnormal_nervous_system | 2.68176092 |
| 15 | * MP0001486_abnormal_startle_reflex | 2.55458391 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.51419312 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.39666673 |
| 18 | MP0002736_abnormal_nociception_after | 2.33573003 |
| 19 | MP0001529_abnormal_vocalization | 2.30622547 |
| 20 | MP0000749_muscle_degeneration | 2.23107854 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.16599927 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.09935500 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.96157422 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.94899696 |
| 25 | MP0001970_abnormal_pain_threshold | 1.93665218 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.93191627 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.89092214 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.86900815 |
| 29 | MP0004924_abnormal_behavior | 1.86900815 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.78352452 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.75783147 |
| 32 | MP0002184_abnormal_innervation | 1.75439462 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.74321855 |
| 34 | MP0001984_abnormal_olfaction | 1.71114268 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.70513512 |
| 36 | MP0008569_lethality_at_weaning | 1.69950713 |
| 37 | MP0003329_amyloid_beta_deposits | 1.69732120 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.69171698 |
| 39 | MP0000747_muscle_weakness | 1.67135333 |
| 40 | MP0004811_abnormal_neuron_physiology | 1.66466487 |
| 41 | MP0000778_abnormal_nervous_system | 1.58268390 |
| 42 | MP0003879_abnormal_hair_cell | 1.58056009 |
| 43 | MP0001905_abnormal_dopamine_level | 1.50000302 |
| 44 | MP0001188_hyperpigmentation | 1.46258366 |
| 45 | MP0000955_abnormal_spinal_cord | 1.44825751 |
| 46 | MP0003787_abnormal_imprinting | 1.44455457 |
| 47 | MP0004858_abnormal_nervous_system | 1.43578745 |
| 48 | * MP0002066_abnormal_motor_capabilities/c | 1.38476695 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.38443147 |
| 50 | MP0004130_abnormal_muscle_cell | 1.36628736 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.35989262 |
| 52 | MP0004087_abnormal_muscle_fiber | 1.34276637 |
| 53 | MP0005620_abnormal_muscle_contractility | 1.30846532 |
| 54 | MP0002106_abnormal_muscle_physiology | 1.29961598 |
| 55 | MP0002269_muscular_atrophy | 1.29203139 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.29156215 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.27569364 |
| 58 | MP0003633_abnormal_nervous_system | 1.21252771 |
| 59 | MP0004147_increased_porphyrin_level | 1.20809420 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.20316049 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.20287808 |
| 62 | MP0004885_abnormal_endolymph | 1.18330526 |
| 63 | MP0008872_abnormal_physiological_respon | 1.14711446 |
| 64 | MP0004142_abnormal_muscle_tone | 1.12961125 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.11687027 |
| 66 | MP0005369_muscle_phenotype | 1.11140540 |
| 67 | MP0003122_maternal_imprinting | 1.09599785 |
| 68 | MP0005409_darkened_coat_color | 1.08335561 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.08142512 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.07689502 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.06422492 |
| 72 | MP0003631_nervous_system_phenotype | 1.05311410 |
| 73 | MP0002152_abnormal_brain_morphology | 1.02984037 |
| 74 | MP0008874_decreased_physiological_sensi | 1.01424253 |
| 75 | MP0000751_myopathy | 0.98935145 |
| 76 | MP0002972_abnormal_cardiac_muscle | 0.98865613 |
| 77 | MP0001177_atelectasis | 0.97937293 |
| 78 | MP0002069_abnormal_eating/drinking_beha | 0.96475930 |
| 79 | MP0004085_abnormal_heartbeat | 0.95834220 |
| 80 | MP0002229_neurodegeneration | 0.93348091 |
| 81 | MP0005330_cardiomyopathy | 0.89545205 |
| 82 | MP0005535_abnormal_body_temperature | 0.88945342 |
| 83 | MP0004510_myositis | 0.88704303 |
| 84 | MP0004742_abnormal_vestibular_system | 0.87137790 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.86154148 |
| 86 | MP0005499_abnormal_olfactory_system | 0.86154148 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.85390294 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.84397819 |
| 89 | MP0002090_abnormal_vision | 0.84261600 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.76380449 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.75064728 |
| 92 | MP0003075_altered_response_to | 0.74964224 |
| 93 | MP0005410_abnormal_fertilization | 0.74280866 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.74257794 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 0.73644543 |
| 96 | MP0000604_amyloidosis | 0.73368267 |
| 97 | MP0001664_abnormal_digestion | 0.72669847 |
| 98 | MP0003632_abnormal_nervous_system | 0.72354100 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.71195753 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.70993867 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.69478596 |
| 102 | MP0005166_decreased_susceptibility_to | 0.69260845 |
| 103 | MP0003634_abnormal_glial_cell | 0.67528382 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.67364530 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.66721895 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.66344217 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.63302612 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.61953837 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.61953837 |
| 110 | MP0000920_abnormal_myelination | 0.61668753 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.61657412 |
| 112 | MP0004484_altered_response_of | 0.61434987 |
| 113 | MP0003690_abnormal_glial_cell | 0.61319358 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.60908331 |
| 115 | MP0004233_abnormal_muscle_weight | 0.58472564 |
| 116 | MP0002102_abnormal_ear_morphology | 0.57876461 |
| 117 | MP0001943_abnormal_respiration | 0.56314811 |
| 118 | MP0003283_abnormal_digestive_organ | 0.55127463 |
| 119 | MP0010769_abnormal_survival | 0.48647911 |
| 120 | MP0010770_preweaning_lethality | 0.48153409 |
| 121 | MP0002082_postnatal_lethality | 0.48153409 |
| 122 | MP0003956_abnormal_body_size | 0.47532046 |
| 123 | MP0003861_abnormal_nervous_system | 0.47420324 |
| 124 | MP0005187_abnormal_penis_morphology | 0.45749049 |
| 125 | MP0000026_abnormal_inner_ear | 0.45681853 |
| 126 | MP0010768_mortality/aging | 0.45532352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.37901148 |
| 2 | Myokymia (HP:0002411) | 7.54296616 |
| 3 | Focal seizures (HP:0007359) | 6.00187861 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 5.50208781 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.28248916 |
| 6 | Nemaline bodies (HP:0003798) | 5.23835498 |
| 7 | Visual hallucinations (HP:0002367) | 4.98007728 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.93204166 |
| 9 | Atonic seizures (HP:0010819) | 4.83089919 |
| 10 | Febrile seizures (HP:0002373) | 4.74452868 |
| 11 | Absence seizures (HP:0002121) | 4.44837376 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.26959965 |
| 13 | Exercise-induced myalgia (HP:0003738) | 4.19425306 |
| 14 | Dialeptic seizures (HP:0011146) | 4.08311779 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 4.07755840 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 4.01245527 |
| 17 | Broad-based gait (HP:0002136) | 3.83677018 |
| 18 | Sudden death (HP:0001699) | 3.80892848 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 3.80635648 |
| 20 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.76085851 |
| 21 | Action tremor (HP:0002345) | 3.71944444 |
| 22 | Hyperventilation (HP:0002883) | 3.68604738 |
| 23 | Bundle branch block (HP:0011710) | 3.66301831 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.54169618 |
| 25 | Poor eye contact (HP:0000817) | 3.51824614 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 3.51376374 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 3.49735980 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 3.41262141 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.38579982 |
| 30 | Anxiety (HP:0000739) | 3.34287796 |
| 31 | Dysdiadochokinesis (HP:0002075) | 3.31893385 |
| 32 | Muscle fiber splitting (HP:0003555) | 3.29943797 |
| 33 | Depression (HP:0000716) | 3.27288459 |
| 34 | Impaired social interactions (HP:0000735) | 3.20242571 |
| 35 | Abnormal social behavior (HP:0012433) | 3.20242571 |
| 36 | Amblyopia (HP:0000646) | 3.20174154 |
| 37 | Truncal ataxia (HP:0002078) | 3.16633846 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 3.11518249 |
| 39 | Ankle clonus (HP:0011448) | 3.11170575 |
| 40 | Dysmetria (HP:0001310) | 3.11051449 |
| 41 | Torticollis (HP:0000473) | 2.99049723 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.97554596 |
| 43 | Distal arthrogryposis (HP:0005684) | 2.93299559 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.93165969 |
| 45 | Rimmed vacuoles (HP:0003805) | 2.91366232 |
| 46 | Heart block (HP:0012722) | 2.87315819 |
| 47 | Frequent falls (HP:0002359) | 2.85649267 |
| 48 | Limb dystonia (HP:0002451) | 2.85628631 |
| 49 | Scanning speech (HP:0002168) | 2.85324045 |
| 50 | Postural instability (HP:0002172) | 2.83585348 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.81995092 |
| 52 | Abnormality of the calf musculature (HP:0001430) | 2.78469821 |
| 53 | Progressive inability to walk (HP:0002505) | 2.76875533 |
| 54 | Myotonia (HP:0002486) | 2.76683780 |
| 55 | Subaortic stenosis (HP:0001682) | 2.76300222 |
| 56 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.76300222 |
| 57 | Excessive salivation (HP:0003781) | 2.75212975 |
| 58 | Drooling (HP:0002307) | 2.75212975 |
| 59 | Focal dystonia (HP:0004373) | 2.72068442 |
| 60 | Mutism (HP:0002300) | 2.68774220 |
| 61 | Myopathic facies (HP:0002058) | 2.67581934 |
| 62 | Urinary urgency (HP:0000012) | 2.66273230 |
| 63 | Difficulty running (HP:0009046) | 2.65197310 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.65060336 |
| 65 | Stereotypic behavior (HP:0000733) | 2.64836504 |
| 66 | Calcaneovalgus deformity (HP:0001848) | 2.60191236 |
| 67 | Cerebral hypomyelination (HP:0006808) | 2.57133097 |
| 68 | Annular pancreas (HP:0001734) | 2.56127384 |
| 69 | Muscle stiffness (HP:0003552) | 2.53578584 |
| 70 | Craniofacial dystonia (HP:0012179) | 2.52101369 |
| 71 | Epileptiform EEG discharges (HP:0011182) | 2.51482798 |
| 72 | Abnormal atrioventricular conduction (HP:0005150) | 2.51472991 |
| 73 | Bradykinesia (HP:0002067) | 2.51433004 |
| 74 | Papilledema (HP:0001085) | 2.51190427 |
| 75 | Resting tremor (HP:0002322) | 2.48465654 |
| 76 | Primary atrial arrhythmia (HP:0001692) | 2.47296107 |
| 77 | Spastic gait (HP:0002064) | 2.46385492 |
| 78 | Genetic anticipation (HP:0003743) | 2.45934215 |
| 79 | Atrial fibrillation (HP:0005110) | 2.45292870 |
| 80 | Hemiparesis (HP:0001269) | 2.42685858 |
| 81 | Dysmetric saccades (HP:0000641) | 2.42221555 |
| 82 | Syncope (HP:0001279) | 2.39321999 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 2.37774431 |
| 84 | Supraventricular tachycardia (HP:0004755) | 2.36510085 |
| 85 | Abnormality of the lower motor neuron (HP:0002366) | 2.36227241 |
| 86 | Inability to walk (HP:0002540) | 2.35837506 |
| 87 | Deformed tarsal bones (HP:0008119) | 2.35461345 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34090916 |
| 89 | Atrioventricular block (HP:0001678) | 2.33564020 |
| 90 | Absent speech (HP:0001344) | 2.33415944 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.31953642 |
| 92 | Termporal pattern (HP:0011008) | 2.29471947 |
| 93 | Insidious onset (HP:0003587) | 2.29471947 |
| 94 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28702360 |
| 95 | Status epilepticus (HP:0002133) | 2.27230117 |
| 96 | Supraventricular arrhythmia (HP:0005115) | 2.26286880 |
| 97 | Fetal akinesia sequence (HP:0001989) | 2.24864275 |
| 98 | Impaired vibratory sensation (HP:0002495) | 2.23305931 |
| 99 | Neurofibrillary tangles (HP:0002185) | 2.23279026 |
| 100 | Neck muscle weakness (HP:0000467) | 2.20947978 |
| 101 | Tetraplegia (HP:0002445) | 2.20499173 |
| 102 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19842258 |
| 103 | Myoglobinuria (HP:0002913) | 2.18594096 |
| 104 | Abnormality of binocular vision (HP:0011514) | 2.18047937 |
| 105 | Diplopia (HP:0000651) | 2.18047937 |
| 106 | EMG: neuropathic changes (HP:0003445) | 2.17783845 |
| 107 | Round ear (HP:0100830) | 2.15641917 |
| 108 | Hypsarrhythmia (HP:0002521) | 2.15024972 |
| 109 | Ventricular fibrillation (HP:0001663) | 2.14682527 |
| 110 | Polyphagia (HP:0002591) | 2.12760645 |
| 111 | Intention tremor (HP:0002080) | 2.12582696 |
| 112 | Pheochromocytoma (HP:0002666) | 2.12065399 |
| 113 | Incomplete penetrance (HP:0003829) | 2.11998481 |
| 114 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11297220 |
| 115 | Protruding tongue (HP:0010808) | 2.09788794 |
| 116 | Rhabdomyolysis (HP:0003201) | 2.08757445 |
| 117 | Akinesia (HP:0002304) | 2.04146974 |
| 118 | Abnormality of the foot musculature (HP:0001436) | 2.03724480 |
| 119 | Blue irides (HP:0000635) | 2.03156415 |
| 120 | Acute necrotizing encephalopathy (HP:0006965) | 2.02983006 |
| 121 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01245837 |
| 122 | Hemiplegia (HP:0002301) | 2.01202923 |
| 123 | Megalencephaly (HP:0001355) | 2.01051001 |
| 124 | Abnormal EKG (HP:0003115) | 2.00962534 |
| 125 | Generalized myoclonic seizures (HP:0002123) | 2.00895548 |
| 126 | Lower limb muscle weakness (HP:0007340) | 2.00857122 |
| 127 | Distal lower limb muscle weakness (HP:0009053) | 2.00715654 |
| 128 | Gait ataxia (HP:0002066) | 1.99091699 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.97539954 |
| 130 | Delusions (HP:0000746) | 1.96853611 |
| 131 | Foot dorsiflexor weakness (HP:0009027) | 1.95527941 |
| 132 | Pointed chin (HP:0000307) | 1.95261572 |
| 133 | Prolonged QT interval (HP:0001657) | 1.94194984 |
| 134 | Ankyloglossia (HP:0010296) | 1.88652974 |
| 135 | Gait imbalance (HP:0002141) | 1.88018770 |
| 136 | Abnormality of the corticospinal tract (HP:0002492) | 1.87508983 |
| 137 | Abnormality of salivation (HP:0100755) | 1.84298469 |
| 138 | Neuronal loss in central nervous system (HP:0002529) | 1.83601702 |
| 139 | Hypoventilation (HP:0002791) | 1.81568001 |
| 140 | Abnormality of saccadic eye movements (HP:0000570) | 1.80417213 |
| 141 | Neuroendocrine neoplasm (HP:0100634) | 1.78858592 |
| 142 | Lower limb asymmetry (HP:0100559) | 1.78104636 |
| 143 | Psychosis (HP:0000709) | 1.77369471 |
| 144 | Rigidity (HP:0002063) | 1.77174451 |
| 145 | Specific learning disability (HP:0001328) | 1.75353484 |
| 146 | Failure to thrive in infancy (HP:0001531) | 1.75069294 |
| 147 | Clonus (HP:0002169) | 1.69309135 |
| 148 | Retinal dysplasia (HP:0007973) | 1.67116441 |
| 149 | Inappropriate behavior (HP:0000719) | 1.66310026 |
| 150 | Agitation (HP:0000713) | 1.63327294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.69741241 |
| 2 | NTRK3 | 4.44668241 |
| 3 | OBSCN | 4.12573881 |
| 4 | MAP3K9 | 3.56141058 |
| 5 | MAP3K4 | 3.00441564 |
| 6 | MINK1 | 2.66999089 |
| 7 | MAP2K7 | 2.56960373 |
| 8 | MARK1 | 2.56543868 |
| 9 | DAPK2 | 2.50277865 |
| 10 | RIPK4 | 2.48187458 |
| 11 | CASK | 2.27131852 |
| 12 | KSR2 | 2.16857132 |
| 13 | MAP3K12 | 2.01167048 |
| 14 | NTRK2 | 1.99161629 |
| 15 | KSR1 | 1.86800270 |
| 16 | PAK6 | 1.85450571 |
| 17 | NTRK1 | 1.79919406 |
| 18 | MAP2K4 | 1.78800253 |
| 19 | DAPK1 | 1.71452237 |
| 20 | CAMKK1 | 1.64056021 |
| 21 | TTN | 1.63052674 |
| 22 | PRKD3 | 1.62798353 |
| 23 | CDK5 | 1.56829227 |
| 24 | ARAF | 1.55401593 |
| 25 | TNIK | 1.51710931 |
| 26 | FES | 1.47762445 |
| 27 | PLK2 | 1.46229744 |
| 28 | PRPF4B | 1.45593550 |
| 29 | MAPK12 | 1.44912947 |
| 30 | SIK2 | 1.43683449 |
| 31 | PNCK | 1.39129581 |
| 32 | MAP3K13 | 1.37518548 |
| 33 | GRK5 | 1.34386415 |
| 34 | MAPK13 | 1.20585247 |
| 35 | PRKCG | 1.18811758 |
| 36 | STK38 | 1.17736647 |
| 37 | MAP3K2 | 1.14418392 |
| 38 | CDK19 | 1.11806586 |
| 39 | BMPR2 | 1.10998440 |
| 40 | CAMK2A | 1.09012976 |
| 41 | CAMKK2 | 1.08068353 |
| 42 | UHMK1 | 1.04504237 |
| 43 | CAMK2B | 0.97267563 |
| 44 | TYRO3 | 0.96976319 |
| 45 | PTK2B | 0.95263977 |
| 46 | SGK223 | 0.94504981 |
| 47 | SGK494 | 0.94504981 |
| 48 | RAF1 | 0.92556011 |
| 49 | CDK18 | 0.91956421 |
| 50 | PKN1 | 0.91669497 |
| 51 | SIK3 | 0.89602532 |
| 52 | PINK1 | 0.88951355 |
| 53 | CDK15 | 0.86530327 |
| 54 | TAOK1 | 0.86098249 |
| 55 | ERBB3 | 0.85951292 |
| 56 | CDK14 | 0.85725591 |
| 57 | CAMK1 | 0.85569770 |
| 58 | SGK2 | 0.81193631 |
| 59 | CDK11A | 0.74679276 |
| 60 | STK11 | 0.73655878 |
| 61 | PRKG1 | 0.72580548 |
| 62 | CSNK1G2 | 0.70909771 |
| 63 | CAMK1G | 0.70292986 |
| 64 | MYLK | 0.70133923 |
| 65 | SGK1 | 0.69964729 |
| 66 | RET | 0.68948964 |
| 67 | PRKCH | 0.68495572 |
| 68 | NME1 | 0.67146309 |
| 69 | MARK2 | 0.66219701 |
| 70 | PHKG2 | 0.65787730 |
| 71 | PHKG1 | 0.65787730 |
| 72 | MOS | 0.64281329 |
| 73 | PIK3CG | 0.64068548 |
| 74 | DYRK1A | 0.64049329 |
| 75 | SGK3 | 0.64046735 |
| 76 | OXSR1 | 0.61966692 |
| 77 | LATS2 | 0.60205306 |
| 78 | CAMK2D | 0.59858232 |
| 79 | FGR | 0.59745107 |
| 80 | MAP3K1 | 0.57135733 |
| 81 | MAP3K11 | 0.55306023 |
| 82 | PRKCE | 0.54180269 |
| 83 | TNK2 | 0.53447519 |
| 84 | PDK1 | 0.52985512 |
| 85 | BCR | 0.52387745 |
| 86 | CAMK2G | 0.51065098 |
| 87 | PRKCZ | 0.49986512 |
| 88 | PDPK1 | 0.49439001 |
| 89 | MAP2K1 | 0.49361694 |
| 90 | LMTK2 | 0.49194563 |
| 91 | PDK2 | 0.49057473 |
| 92 | BRAF | 0.47892707 |
| 93 | RPS6KA3 | 0.47648227 |
| 94 | PAK3 | 0.45731886 |
| 95 | PRKACB | 0.44936224 |
| 96 | FYN | 0.44880444 |
| 97 | AKT3 | 0.44858112 |
| 98 | MAPK10 | 0.42672147 |
| 99 | CCNB1 | 0.41720135 |
| 100 | MAPK7 | 0.41465887 |
| 101 | CAMK4 | 0.40685740 |
| 102 | MAPK4 | 0.40557030 |
| 103 | TRPM7 | 0.39255145 |
| 104 | NEK1 | 0.38896602 |
| 105 | DAPK3 | 0.38848928 |
| 106 | PRKCA | 0.38428948 |
| 107 | GRK7 | 0.37392945 |
| 108 | MUSK | 0.37119057 |
| 109 | FER | 0.37062317 |
| 110 | ROCK1 | 0.36775396 |
| 111 | PRKCB | 0.36747184 |
| 112 | NEK6 | 0.36488114 |
| 113 | ALK | 0.34334989 |
| 114 | WNK3 | 0.34112586 |
| 115 | PRKACA | 0.33536307 |
| 116 | BLK | 0.33071172 |
| 117 | MAP2K6 | 0.33046789 |
| 118 | WNK1 | 0.32906742 |
| 119 | ROCK2 | 0.31648299 |
| 120 | CSNK1E | 0.31226272 |
| 121 | MAP3K7 | 0.29959516 |
| 122 | JAK2 | 0.28217085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.97095967 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.25404142 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.98494711 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.83436126 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79300804 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.79213294 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.72986923 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.72947882 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.71250218 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63463794 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.34996333 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.20185266 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.03058169 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 2.02550039 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99234031 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.88866759 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.88623568 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.85993948 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.83580912 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81899207 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78427355 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.77323764 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73894610 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.67381290 |
| 25 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66685002 |
| 26 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59557718 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.50091359 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46086752 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.44584442 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33149471 |
| 31 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.31898737 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29604044 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25870738 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25683944 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23021719 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.17536227 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11777121 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.07251126 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04169864 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03683666 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03682810 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.03588324 |
| 43 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02075794 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00991388 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96997201 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.96700094 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96419328 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95920571 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94019848 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90667539 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87213222 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86826829 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85609069 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79512126 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79059139 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76420740 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74026244 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73239597 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72166512 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.70069662 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69906158 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69141373 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68770206 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68264308 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66691393 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65039413 |
| 67 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63364000 |
| 68 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62799529 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61156791 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59113124 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58822562 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58262424 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56669629 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55601648 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54590174 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54399281 |
| 77 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53089905 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53043420 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52722834 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.52521357 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51569951 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.51481650 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51414034 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49337762 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48626232 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47698029 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46077359 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45008940 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44624501 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44621731 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43541544 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43402484 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40198946 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39318474 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.37120489 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37102592 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.36450509 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36302665 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.36270378 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35142013 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35124539 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.33585863 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33123751 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33094694 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33077289 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32633382 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32268198 |
| 108 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31798441 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31402925 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29987656 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29654800 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29055211 |
| 113 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28180293 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27801978 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26085451 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26004286 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25286222 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.22988268 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22870216 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19716418 |

